DYNAMICS OF CHANGES IN PATHOGENIC CHARACTERISTICS OF BORDETELLA PERTUSSIS STRAINS


Cite item

Full Text

Abstract

Aim. To study pathogenic characteristics of B.pertussis strains isolated from patients during different periods of pertussis infection epidemic process. Materials and methods. Strains of B.pertussis isolated in Moscow during 1967 — 1971, 1980 — 1985, and 2001 — 2005 were studied. Nutrient media: Bordet-Gengou blood agar, casein-charcoal agar. Animals: mice – F1 hybrids (CBA x C57BL6). Pathogenic characteristics of strains were studied by assessment of virulence (LD50), leukocytosisstimulating (LS units) and histamine-sensitizing (HSD50) activities of cultures. Genotyping was performed using standard equipment and reagents for DNA isolation, amplification, sequencing and detection of results. Results. On the sample of 164 strains, pathogenic and genotypic characteristics of B.pertussis populations circulated during 1967 — 1971, 1980 — 1985, and 2001 — 2005. Majority of B.pertussis strains isolated in 1967 — 1971 and strains circulated during current phase of epidemic process were virulent (80.75% and 81.8% respectively) and had significant leukocytosis-stimulating and histamine-sensitizing activity, whereas strains isolated from patients with pertussis in 1980 — 1985 characterized by lower virulence and toxicity. Genotyping showed strains carrying «non-vaccine» allele ptxA1, which emerged in the middle of 1970s, totally displaced strains with «vaccine» alleles ptxA2 and ptxA4. Conclusion. Adaptive changes of B.pertussis driven by increased vaccination coverage involve both ptxA gene and pathogenic characteristics of infectious agent in the range of genotypically homogenous population with domination of strains, which have high levels of virulence and toxicity.

Full Text

ДИНАМИКА ИЗМЕНЕНИЙ ПАТОГЕННЫХ СВОЙСТВ ШТАММОВ BORDETELLA PERTUSSIS
×

About the authors

N. U Mertsalova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

O. Yu Borisova

Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia

A. S Shinkarev

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

M. V Britsina

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

M. N Ozeretskovskaya

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

I. K Mazurova

Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia

V. A Aleshkin

Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia

N. T Gadua

Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia

N. S Zakharova

Mechnikov Research Institute of Vaccines and Sera, Moscow, Russia

References

  1. Борисова И.Э., Селезнева Т.С. Антигенный дрейф коклюшного микроба. Эпидемиол. вакцинопроф. 2008, 1: 39-44.
  2. Герасимова А.Г., Петрова М.С., Тихонова Н.Т. и др. Клинико-эпидемиологическая характеристика современного кок люша. Вакцинация. Новости вакцинопрофилактики. 2004, 5 (35): 4-5.
  3. Ефимова О.Г., Сигаева Л.А., Савинкова В.С. и др. Характеристика свойств штаммов возбудителя коклюша, выделенных от больных в 1980-90-е годы в Москве. В: Актуальные проблемы инфекционной патологии. М., 1993, 1: 119.
  4. Мазурова И.К., Борисова О.Ю., Комбарова С.Ю. и др. Динамика изменчивости основных генов патогенности штаммов Bordetella pertussis, выделенных от больных коклюшем в г. Москве (1948 — 2005 гг.). Журн. мол. мед. 2008, 1: 40-45.
  5. Семенов Б.Ф., Захарова Н.С., Мазурова И.К. Подъем заболеваемости коклюшем на фоне массовой вакцинации. Гипотезы, объясняющие этот феномен. Журн. микробиол. 2003, 6: 70-73.
  6. Сигаева Л.А., Кузнецова Л.С., Окиншевич Е.А. Заболеваемость коклюшем и состояние привитости. Там же. 1986, 3: 43-47.
  7. Шинкарев А.С., Мерцалова Н.У., Мазурова И.К. и др. Современные штаммы Bordetella pertussis: молекулярная и иммунобиологическая характеристика. Там же. 2007, 4: 20-25.
  8. Чистякова Г.Г., Борисова О.Ю., Лыткина И.Н. и др. Особенности эпидемического процесса коклюшной инфекции в Москве на современном этапе. Там же. 2005, 5: 35-40.
  9. Borisova O., Kombarova S.J., Zakharova N.S. et al. Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia and vaccine strains. J. Clin. Vacc. Immunol. 2007, 14 (3): 234-238.
  10. Mooi F.R., Hallander H., Virsing von Konig C.H. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19(3):174-81.
  11. Van Amersfoorth S.C., Schouls L. M., van der Heide H.G. et al. Analysis of B.pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 2005, 43: 2837-2843.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2009 Mertsalova N.U., Borisova O.Y., Shinkarev A.S., Britsina M.V., Ozeretskovskaya M.N., Mazurova I.K., Aleshkin V.A., Gadua N.T., Zakharova N.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies